Science Applications Intl Analyst Ratings
Science Applications Intl Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/02/2023 | 6.62% | Stifel | → $115 | Reiterates | Hold → Hold |
| 06/06/2023 | 6.62% | Truist Securities | $120 → $115 | Maintains | Hold |
| 04/12/2023 | 3.84% | Stifel | $110 → $112 | Maintains | Hold |
| 04/06/2023 | -10.07% | Goldman Sachs | $90 → $97 | Maintains | Sell |
| 04/04/2023 | 9.4% | Wells Fargo | $121 → $118 | Maintains | Equal-Weight |
| 04/04/2023 | 17.75% | Citigroup | $141 → $127 | Maintains | Buy |
| 01/03/2023 | 5.69% | Morgan Stanley | $108 → $114 | Downgrades | Overweight → Equal-Weight |
| 12/06/2022 | -12.85% | Goldman Sachs | $83 → $94 | Maintains | Sell |
| 11/17/2022 | 1.98% | Jefferies | → $110 | Downgrades | Buy → Hold |
| 06/08/2022 | -11.92% | Barclays | $90 → $95 | Maintains | Equal-Weight |
| 06/07/2022 | 11.26% | Cowen & Co. | $111 → $120 | Maintains | Outperform |
| 06/07/2022 | -11.92% | Barclays | $90 → $95 | Maintains | Equal-Weight |
| 04/01/2022 | -2.65% | Truist Securities | → $105 | Downgrades | Buy → Hold |
| 03/29/2022 | -8.21% | Morgan Stanley | $101 → $99 | Maintains | Overweight |
| 03/24/2022 | -11% | Wells Fargo | $90 → $96 | Maintains | Equal-Weight |
| 03/18/2022 | -6.36% | Morgan Stanley | $98 → $101 | Maintains | Overweight |
| 01/24/2022 | -16.56% | Barclays | $105 → $90 | Downgrades | Overweight → Equal-Weight |
| 01/03/2022 | -9.14% | Morgan Stanley | $101 → $98 | Maintains | Overweight |
| 12/07/2021 | -13.78% | Wells Fargo | $90 → $93 | Maintains | Equal-Weight |
| 10/27/2021 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 06/07/2021 | -6.36% | Morgan Stanley | $97 → $101 | Maintains | Overweight |
| 05/13/2021 | -11.92% | Wells Fargo | → $95 | Initiates Coverage On | → Equal-Weight |
| 05/12/2021 | -7.29% | Barclays | $107 → $100 | Maintains | Overweight |
| 04/07/2021 | -10.07% | Morgan Stanley | $107 → $97 | Maintains | Overweight |
| 04/05/2021 | -17.49% | Goldman Sachs | $96 → $89 | Downgrades | Buy → Neutral |
| 03/30/2021 | -11.92% | JP Morgan | $110 → $95 | Maintains | Overweight |
| 03/26/2021 | -2.65% | Citigroup | $115 → $105 | Maintains | Buy |
| 03/26/2021 | -16.56% | Stifel | → $90 | Downgrades | Buy → Hold |
| 12/04/2020 | -9.14% | Morgan Stanley | $94 → $98 | Maintains | Overweight |
| 09/03/2020 | -2.65% | Citigroup | $100 → $105 | Maintains | Buy |
| 05/19/2020 | -2.65% | Wells Fargo | $85 → $105 | Maintains | Overweight |
| 04/20/2020 | — | Goldman Sachs | Upgrades | Neutral → Buy | |
| 04/14/2020 | -12.85% | Morgan Stanley | $91 → $94 | Maintains | Overweight |
| 04/02/2020 | -11.92% | Stifel | → $95 | Upgrades | Hold → Buy |
| 03/31/2020 | -15.63% | Morgan Stanley | $85 → $91 | Maintains | Overweight |
| 03/31/2020 | — | William Blair | Initiates Coverage On | → Outperform | |
| 03/30/2020 | -11.92% | SunTrust Robinson Humphrey | $110 → $95 | Maintains | Buy |
| 03/27/2020 | -7.29% | Citigroup | $105 → $100 | Maintains | Buy |
| 03/27/2020 | -21.19% | Wells Fargo | $105 → $85 | Maintains | Overweight |
| 03/27/2020 | -2.65% | Benchmark | $115 → $105 | Maintains | Buy |
| 03/24/2020 | -21.19% | Morgan Stanley | $108 → $85 | Maintains | Overweight |
| 01/31/2020 | — | Benchmark | Initiates Coverage On | → Buy | |
| 01/09/2020 | -7.29% | Wells Fargo | $92 → $100 | Maintains | Overweight |
| 09/24/2019 | -5.43% | JP Morgan | → $102 | Initiates Coverage On | → Overweight |
| 09/20/2019 | -2.65% | Barclays | → $105 | Initiates Coverage On | → Overweight |
| 09/09/2019 | — | Cowen & Co. | Upgrades | Market Perform → Outperform | |
| 06/03/2019 | -11% | Morgan Stanley | → $96 | Initiates Coverage On | → Overweight |
| 05/16/2019 | — | Wells Fargo | Upgrades | Market Perform → Outperform | |
| 05/09/2019 | -28.61% | Goldman Sachs | → $77 | Initiates Coverage On | → Neutral |
| 03/29/2019 | -28.61% | Wells Fargo | $70 → $77 | Maintains | Market Perform |
| 03/29/2019 | — | Vertical Research | Upgrades | Hold → Buy | |
| 12/07/2018 | -30.47% | Wells Fargo | $84 → $75 | Maintains | Market Perform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 10/02/2023 | 6.62% | Stifel | →$115 | 重申 | 保持→保持 |
| 06/06/2023 | 6.62% | Truist證券 | $120→$115 | 維護 | 保持 |
| 04/12/2023 | 3.84% | Stifel | $110→$112 | 維護 | 保持 |
| 04/06/2023 | -10.07% | 高盛 | $90→$97 | 維護 | 賣 |
| 04/04/2023 | 9.4% | 富國銀行 | $121→$118 | 維護 | 等重 |
| 04/04/2023 | 17.75% | 花旗集團 | $141→$127 | 維護 | 買 |
| 01/03/2023 | 5.69% | 摩根士丹利 | $108→$114 | 評級下調 | 超重→等重 |
| 12/06/2022 | -12.85% | 高盛 | $83→$94 | 維護 | 賣 |
| 2022年11月17日 | 1.98% | 傑富瑞 | →$110 | 評級下調 | 購買→Hold |
| 06/08/2022 | -11.92% | 巴克萊 | $90→$95 | 維護 | 等重 |
| 06/07/2022 | 11.26% | 考恩公司 | $111→$120 | 維護 | 跑贏大盤 |
| 06/07/2022 | -11.92% | 巴克萊 | $90→$95 | 維護 | 等重 |
| 04/01/2022 | -2.65% | Truist證券 | →$105 | 評級下調 | 購買→Hold |
| 03/29/2022 | -8.21% | 摩根士丹利 | $101→$99 | 維護 | 超重 |
| 03/24/2022 | -11% | 富國銀行 | $90→$96 | 維護 | 等重 |
| 03/18/2022 | -6.36% | 摩根士丹利 | $98→$101 | 維護 | 超重 |
| 01/24/2022 | -16.56% | 巴克萊 | $105→$90 | 評級下調 | 超重→等重 |
| 01/03/2022 | -9.14% | 摩根士丹利 | $101→$98 | 維護 | 超重 |
| 12/07/2021 | -13.78% | 富國銀行 | $90→$93 | 維護 | 等重 |
| 10/27/2021 | - | 威廉·布萊爾 | 評級下調 | 跑贏→市場表現 | |
| 06/07/2021 | -6.36% | 摩根士丹利 | $97→$101 | 維護 | 超重 |
| 2021/05/13 | -11.92% | 富國銀行 | →$95 | 開始承保 | →等重 |
| 2021/05/12 | -7.29% | 巴克萊 | $107→$100 | 維護 | 超重 |
| 04/07/2021 | -10.07% | 摩根士丹利 | $107→$97 | 維護 | 超重 |
| 04/05/2021 | -17.49% | 高盛 | $96→$89 | 評級下調 | 購買→中性 |
| 03/30/2021 | -11.92% | 摩根大通 | $110→$95 | 維護 | 超重 |
| 03/26/2021 | -2.65% | 花旗集團 | $115→$105 | 維護 | 買 |
| 03/26/2021 | -16.56% | Stifel | →$90 | 評級下調 | 購買→Hold |
| 12/04/2020 | -9.14% | 摩根士丹利 | $94→$98 | 維護 | 超重 |
| 09/03/2020 | -2.65% | 花旗集團 | $100→$105 | 維護 | 買 |
| 2020/05/19 | -2.65% | 富國銀行 | $85→$105 | 維護 | 超重 |
| 04/20/2020 | - | 高盛 | 升級 | 中性→購買 | |
| 04/14/2020 | -12.85% | 摩根士丹利 | $91→$94 | 維護 | 超重 |
| 04/02/2020 | -11.92% | Stifel | →$95 | 升級 | 持有→購買 |
| 03/31/2020 | -15.63% | 摩根士丹利 | $85→$91 | 維護 | 超重 |
| 03/31/2020 | - | 威廉·布萊爾 | 開始承保 | →跑贏大盤 | |
| 03/30/2020 | -11.92% | SunTrust Robinson Humphrey | $110→$95 | 維護 | 買 |
| 03/27/2020 | -7.29% | 花旗集團 | $105→$100 | 維護 | 買 |
| 03/27/2020 | -21.19% | 富國銀行 | $105→$85 | 維護 | 超重 |
| 03/27/2020 | -2.65% | 基準 | $115→$105 | 維護 | 買 |
| 03/24/2020 | -21.19% | 摩根士丹利 | $108→$85 | 維護 | 超重 |
| 2020/01/31 | - | 基準 | 開始承保 | →購買 | |
| 1/09/2020 | -7.29% | 富國銀行 | $92→$100 | 維護 | 超重 |
| 2019年09月24日 | -5.43% | 摩根大通 | →$102 | 開始承保 | →超重 |
| 2019年09月20日 | -2.65% | 巴克萊 | →$105 | 開始承保 | →超重 |
| 2019年09月09日 | - | 考恩公司 | 升級 | 市場表現優於→ | |
| 2019年03月06日 | -11% | 摩根士丹利 | →$96 | 開始承保 | →超重 |
| 2019年05月16日 | - | 富國銀行 | 升級 | 市場表現優於→ | |
| 2019年05月09日 | -28.61% | 高盛 | →$77 | 開始承保 | →中性 |
| 2019/03/29 | -28.61% | 富國銀行 | $70→$77 | 維護 | 市場表現 |
| 2019/03/29 | - | 垂直研究 | 升級 | 持有→購買 | |
| 2018年12月07日 | -30.47% | 富國銀行 | $84→$75 | 維護 | 市場表現 |
What is the target price for Science Applications Intl (SAIC)?
科學應用國際(SAIC)的目標價格是多少？
The latest price target for Science Applications Intl (NYSE: SAIC) was reported by Stifel on October 2, 2023. The analyst firm set a price target for $115.00 expecting SAIC to rise to within 12 months (a possible 6.62% upside). 9 analyst firms have reported ratings in the last year.
科學應用國際公司(紐約證券交易所代碼：SAIC)的最新目標價是由Stifel於2023年10月2日報道的。這家分析公司將目標股價定為115.00美元，預計上汽集團股價將在12個月內上漲(漲幅可能為6.62%)。去年有9家分析公司公佈了評級。
What is the most recent analyst rating for Science Applications Intl (SAIC)?
科學應用國際(SAIC)的最新分析師評級是多少？
The latest analyst rating for Science Applications Intl (NYSE: SAIC) was provided by Stifel, and Science Applications Intl reiterated their hold rating.
科學應用國際公司(紐約證券交易所代碼：SAIC)的最新分析師評級由Stifel提供，科學應用國際公司重申其持有評級。
When is the next analyst rating going to be posted or updated for Science Applications Intl (SAIC)?
科學應用國際(SAIC)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Science Applications Intl, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Science Applications Intl was filed on October 2, 2023 so you should expect the next rating to be made available sometime around October 2, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與Science Applications Intl的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。科學應用國際的最後一次評級是在2023年10月2日提交的，所以你應該預計下一次評級將在2024年10月2日左右的某個時候提供。
Is the Analyst Rating Science Applications Intl (SAIC) correct?
分析師對科學應用國際(SAIC)的評級正確嗎？
While ratings are subjective and will change, the latest Science Applications Intl (SAIC) rating was a reiterated with a price target of $0.00 to $115.00. The current price Science Applications Intl (SAIC) is trading at is $107.86, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的科學應用國際(SAIC)評級被重申，目標價在0.00美元至115.00美元之間。科學應用國際公司目前的交易價格為107.86美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。